Niti

The Global Shape Memory Alloy Market (2018-2022); ATI, Furukawa Electric, Johnson Matthey, Nippon Seisen, and SAES Group are Dominating - ResearchAndMarkets.com

Retrieved on: 
Friday, January 11, 2019
Other Consumer, Health, Biotechnology, Manufacturing, Aerospace, Automotive Manufacturing, Natural Resources, Mining, Minerals, Automotive, Tires & Rubber, Consumer, Chemistry, Smart materials, Materials science, Nickel titanium, Solid-state chemistry, United States Navy, Shape-memory alloy, Niti, Nitinol 60

The "Global Shape Memory Alloy Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Shape Memory Alloy Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
  • The shape memory alloy market will register a CAGR of over 9% by 2022.
  • The NASA has developed tires meant for the rover destined for the Mars by using shape memory alloys.
  • Nitinol exhibits super elasticity, shape memory, and corrosion resistance properties.

The shape memory alloy market will register a CAGR of over 9% by 2022

Retrieved on: 
Thursday, January 10, 2019
Chemistry, Smart materials, Materials science, Alloys, Nickel titanium, United States Navy, Shape-memory alloy, Niti, Tire

Development of tires with shape memory alloy to drive market growth.

Key Points: 
  • Development of tires with shape memory alloy to drive market growth.
  • Technavio's analysts have predicted that the shape memory alloy market will register a CAGR of over 9% by 2022.
  • For the detailed list of factors that will drive and challenge the growth of the shape memory alloy market during the 2018-2022, view our report.
  • Factors such as the development of tires with shape memory alloy and the biocompatibility of Nitinol, will provide considerable growth opportunities to shape memory alloy manufactures.

Kezar Life Sciences Strengthens Management Team with the Appointments of Niti Goel, MD, as Chief Medical Officer and Marc Belsky as Chief Financial Officer

Retrieved on: 
Tuesday, May 1, 2018
Computer telephony integration, Genesys, Niti, Belsky, Economy of the United States

SOUTH SAN FRANCISCO, Calif., May 1, 2018 /PRNewswire/ --Kezar Life Sciences, a private, clinical-stage biotechnology company discovering and developing novel small molecule therapeutics, today announced the appointments of Niti Goel, MD, as Chief Medical Officer and Marc Belsky as Chief Financial Officer.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., May 1, 2018 /PRNewswire/ --Kezar Life Sciences, a private, clinical-stage biotechnology company discovering and developing novel small molecule therapeutics, today announced the appointments of Niti Goel, MD, as Chief Medical Officer and Marc Belsky as Chief Financial Officer.
  • "We are delighted to welcome Niti and Marc to the team," said John Fowler, Co-founder and Chief Executive Officer of Kezar Life Sciences.
  • "Niti is a gifted clinician whose unique background, including in academia and full-phase drug development leading to commercialization, will be a tremendous asset to Kezar.
  • Prior to Five Prime, Mr. Belsky was Chief Accounting Officer of Cell Genesys, and has held multiple other Chief Financial Officer and finance-related positions.